A recent study on osteosarcoma (OS) revealed that the inhibition of METTL3 can disrupt Wnt signaling activity by altering the m6A levels of LEF1, resulting in the suppression of proliferation, migration, and invasion in OS cells [44]. Here, METTL3 is linked to osteosarcoma.